

Cover Story
Free
This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, the Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
In Brief


Drugs & Targets
Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned











